News Desk
Every PSA story filed under the Psychedelics desk.
Share this page
DEA judge pauses the marijuana rescheduling hearing after opponents cited a GAO report finding DEA and FDA lack written scheduling procedures. Plus: New Mexico psilocybin rules and ARPA-H's SURPASS.
Share
Plus: This Thursday - "Evaluating the Next Generation of Psychedelic Higher Education" and the PSA NewsWire Highlights of the Week
A Discussion on the Future of Psychedelic Discourse feat. PGN Founder Ashley Carmen and PSA Founder Jack Gorsline
Join Psychedelic State(s) of America and The Psychedelic Bar Association tonight for a live discussion exploring the evolving legal frameworks and ethical considerations shaping the future of psychedelic discourse.
Treatment deemed effective, “without triggering mania or psychosis” in patients with Bipolar Disorder
"Diving Deep: The Parallel Journeys of Scuba and Psychedelics," “The Psychedelic Church Membership Screening Process that Weeded Out Multiple Undercover Informants,” plus the PSA NewsWire Highlights of the Week
Part 2 in a two-part series about the lack of representation in psychedelic research, from our friends at TalkingDrugs
"The Representation Crisis: The Problem in the Medicalized Psychedelics Model" from our friends at TalkingDrugs, ICYMI: The Psychedelic Bookshelf, Vol. IV, plus The PSA NewsWire Highlights of the Week!
New Study Highlights “high satisfaction” with regulated psilocybin services in Oregon and Low Rate of Adverse Events
Produced in partnership with our friends at Psychedelics Today
Part 1 in a two-part series about the lack of representation in psychedelic research, from our friends at TalkingDrugs
From our friends at Filter Magazine
Amidst political turmoil on the island, Puerto Rico takes the lead on next-gen clinical psychedelic research
Feat. Congregation for Sacred Practices Founder Paul Ryder, Singularism Founder Bridger Lee Jensen, and PSA Founder Jack Gorsline
Streaming Live via PSA and powered by our friends at Psychedelics Today and Lucid News
Produced in partnership with our friends at Psychedelics Today: The Texas Ibogaine Initiative launches Phase I Clinical Trials with extra $50 million in state funds, Eli Lilly buys Atai-Beckley for up to $3.8 Billion, Dr.…
Help Psychedelic State(s) of America chart a new course for rigorous psychedelic journalism for the people, by the people
Plus, ICYMI: Inside Massachusetts' latest Psychedelic Policy Breakthrough
PSA and the Psychedelic Writers Guild take Denver next month, with coverage, events, and community offerings galore already in the works
Streaming Live via PSA and our friends at Psychedelics Today
Guest Column from SSDP NYC Chapter President Zach Johnson, PSA Media Partner Announcement, plus an extended edition this week's PSA Media NewsWire Highlights
From our friends at The Chronicles of Kykeon:
Part 7 of exposé on Massachusetts’ 2024 psychedelics campaign from its educational director details how the campaign possibly put Its Grassroots Staff and Nonprofit Affiliates in Legal Jeopardy
Part 6.2 of exposé on Massachusetts’ 2024 psychedelics campaign from its educational director details glaring conflicts of interest
Legislative proposals present differing pilot programs, sparking debate among experts and advocates on the future of psychedelics
Why your mind belongs to you and why that matters.
11.9.2025 email introduction
Part 3 of a postmortem of the 2024 Massachusetts psychedelics campaign
11.6.2025 email introduction
Part 2.3 of a postmortem of the 2024 Massachusetts psychedelics campaign
10.31.2025 email introduction
Part 2.2 of a postmortem of the 2024 Massachusetts psychedelics campaign
“For the first time, I was able to let go of the blame and guilt and shame that I kept bottled up from the military.”
Functional mushrooms offer health benefits beyond basic nutrition. They contain bioactive compounds, such as polysaccharides, beta-glucans, triterpenoids, and antioxidants, contributing to their therapeutic properties.
Neuroplasticity has become one of those words that gets tossed around everywhere, from wellness blogs to neuroscience labs to psychedelic therapy retreats.
An interview with New England’s newest “friendly neighborhood safety dealers” about the importance of psychedelics education
A “quirky brand of integration wisdom” with Tam Integration founder Daniel Shankin
What's Happened, What's Up Next, and Other Odds, Ends, and Overdue Substack-Specific Updates
10.17.2025 email introduction
An overdue (re)-introduction, plus What's Next for Psychedelics in Texas?, previewing PSA's ACT Conference recap, upcoming events worth attending, and more!
LIVE From Austin, Texas tonight, tomorrow, & Thursday + the latest ACT Conference Coverage Preview!
Plus, tune in LIVE next Tuesday night for The Lone Star Plant Medicine Showcase!
Getting up to speed before getting back on the road
Inside the debut of Boston's newest psychedelic education and advocacy forum, viewing info for local and online attendees, plus a brief overview of PSA's soon-to-be regularly scheduled programming...
Plus, a brief but undoubtedly overdue update.
"Stolen Valor" update(s), industry highlights, a shameless plug, and a sneak peak (or two).
1 In this week’s slightly less-psychedelic feature Q+A, I spoke with Mr. David Babik, President of the Boston Mycological Club.…
Co-founder of the Psychedelic Pharmacists' Association
This is Psychedelic State(s) of America.
